As an Add-on to Metformin Monotherapy The reduction in HbA1c in T2DM patients on metformin monotherapy with SGLT2i + DPP4i FDCs is compared in Table 3
The cagrilintide and retatrutide combination is an area of active interest
In the SURMOUNT-1 study, in fact, over 95% of participants with prediabetes were able to achieve normalization of blood glucose after 72 weeks of treatment with tirzepatide, the first GIP/GLP-1 receptor co-agonist representing this new class of drugs, compared to 62% of the control group [57]
Patients should avoid injecting into areas with scarring, bruising, inflammation, or skin conditions
Cagrilintide-semaglutide in adults with overweight or obesity and type 2 diabetes
They only offer injections, not oral tablets